Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
155 Cards in this Set
- Front
- Back
Herpes genitalis
|
recurrent painful vesicles; multinucleated squamous cells with intranuclear inclusions
|
|
Human papilloma virus
|
condyloma acuminata; koilocytosis (wrinkled nuclei surrounded by a halo)
|
|
Chlamydia trachomatis
|
metaplastic squamous cells with vacuoles containing elementary bodies
|
|
S/S of Chlamydia
|
non-specific urethritis, cervicitis, PID, ophthalmia neonatorum
|
|
Neisseria gonorrhoeae
|
urethritis, cervicitis, PID; ophthalmia neonatorum, gram negative diplococcus
|
|
Ophthalmia neonatorum first week
|
N. gonorrhoeae
|
|
Ophthalmia neonatorum second week
|
C. trachomatis
|
|
Lymphogranuloma venereum
|
C. trachomatis subtype
|
|
Lymphogranuloma venereum S/S
|
scrotal/vulva lymphedema; granulomatous micrcabscesses; rectal strictures in females
|
|
Chancroid
|
painful ulcer, adenopathy, Hemophilus ducreyi
|
|
Granuloma inguinale
|
Calymmatobacterium granulomatis; raised ulceration but no lymphadenopathy
|
|
Treponema pallidum
|
spirochete; produces vasculitis of arterioles (plasma cell infiltrate)
|
|
Primary syphilis
|
painless chancre
|
|
rash on palms/soles; condyloma lata; generalized adenopathy
|
Secondary syphilis
|
|
Tertiary syphilis
|
neurosyphilis (e.g., tabes dorsalis), aortic arch aneurysm, gummas
|
|
RPR/VDRL positive
|
reagin antibodies against cardiolipin; • titer with Rx of syphilis
|
|
false positive RPR/VDRL
|
with anticardiolipin antibodies (common in SLE)
|
|
FTA-ABS positive
|
confirmatory test for syphilis; not distinguish active from treated disease, remains positive after Rx
|
|
Trichomonas vaginalis
|
flagellate protozoan; cervicitis/vaginitis; Rx metronidazole both partners
|
|
Gardnerella vaginalis
|
vaginal pH > 5; bacterial vaginosis; clue cells; Rx metronidazole
|
|
Candida vaginitis
|
white, curd-like discharge; DM, antibiotics, pregnancy; Rx fluconazole
|
|
Vulvar squamous cancer
|
MC vulvar cancer; HPV association
|
|
Vulvar leukoplakia
|
biopsy to R/O squamous dysplasia/cancer
|
|
Lichen sclerosis vulva
|
epidermal atrophy; slight risk for squamous cancer
|
|
Squamous hyperplasia vulva
|
leukoplakia; no cancer risk
|
|
Paget's disease
|
intraepithelial adenocarcinoma (mucin production) of vulva
|
|
Malignant melanoma of the vulva
|
vulva location; similar to Paget cells but not mucin positive
|
|
Gartner's duct cyst
|
lateral wall vagina; persistent mesonephric duct
|
|
Embryonal rhabdomyosarcoma
|
bloody, grape-like vaginal mass young girl
|
|
Vaginal adenosis
|
maternal exposure to DES; precursor clear cell adenocarcinoma vagina
|
|
Vaginal squamous cancer
|
usually extension of cervical cancer
|
|
Rokitansky-Koster-Hauser
|
absence of vagina and uterus
|
|
Nabothian cysts
|
endocervical glands covered by metaplastic squamous epithelium
|
|
Pathologic cervicitis
|
trichomonas, HSV-2, C. trachomatis (follicular cervicitis)
|
|
Cervical Pap
|
superficial squamous (estrogen), intermediate (progesterone), parabasal (no hormone)
|
|
Normal Pap Smear
|
70% superficial, 30% intermediate
|
|
Atrophic pap smear
|
100% parabasal cells
|
|
Pap smear in Hyperestrinism
|
100% superficial cells
|
|
Pap smear in pregnancy
|
100% intermediate cells
|
|
Endocervical cells in Pap smear
|
sign of adequately performed Pap smear
|
|
Cervical polyp
|
bleeding after intercourse; non-neoplastic
|
|
Cervical dysplasia
|
begins in transformation zone; associated with low and high risk HPV
|
|
Risk factors of cervical dysplasia/cancer
|
early onset sexual activity; multiple partners; smoking; OC
|
|
CIN
|
cervical intraepithelial dysplasia; mild, moderate, severe (in-situ)
|
|
Cervical cancer
|
dec incidence (Pap smear); 45-yr-old; COD renal failure from obstruction of ureters
|
|
S/S of Cervical cancer
|
cervical discharge; bleeding after intercourse
|
|
Sequence to menarche
|
breast budding, growth spurt, pubic hair, axillary hair, menarche
|
|
Proliferative phase cycle
|
estrogen-dependent; inc estrogen inhibits FSH and stimulates LH
|
|
Ovulation
|
day 14-16; LH surge; subnuclear vacuoles; inc body temperature
|
|
Secretory phase cycle
|
progesterone-dependent
|
|
Menses
|
drop in estrogen/progesterone stimulates apoptosis; plasmin prevents clotting
|
|
FSH action
|
stimulates follicle and aromatase synthesis in granulosa cells
|
|
LH action
|
stimulates androgen synthesis in proliferative phase and progesterone synthesis in secretory phase
|
|
Day 21 of cycle
|
day of implantation of fertilized egg
|
|
Pregnancy effects
|
inc plasma volume > RBC mass; inc GFR; inc thyroxine/cortisol (increased binding proteins)
|
|
hCG
|
LH analogue produced by syncytiotrophoblast
|
|
hCG
|
stimulates corpus luteum of pregnancy to synthesize progesterone for 8-10 weeks
|
|
Estrone
|
estrogen of postmenopausal woman; aromatization of adrenal androstenedione
|
|
Estradiol
|
estrogen of non-pregnant woman in reproductive life; aromatization of testosterone
|
|
Estriol
|
estrogen of pregnancy
|
|
Menopause
|
inc FSH (best screen; due to dec estrogen), inc LH
|
|
S/S of Menopause
|
secondary amenorrhea, hot flushes
|
|
Hirsutism
|
inc hair in normal areas
|
|
Virilization
|
hirsutism + male secondary sex characteristics (clitoromegaly)
|
|
Test for hirsutism/virilization
|
inc testosterone- ovarian source; inc DHEA-sulfate- adrenal source
|
|
Polycystic ovarian syndrome (PCOS)
|
inc LH; dec FSH; inc estrogen and androgens
|
|
S/S of PCOS
|
hirsutism, oligomenorrhea, infertility; enlarged ovaries with subcortical cysts; LH:FSH > 2:1
|
|
Menorrhagia
|
excess menstrual flow; MCC iron deficiency in women
|
|
Dysmenorrhea
|
painful menses; primary PGF2a, secondary endometriosis
|
|
DUB
|
bleeding related to hormone rather than anatomic causes
|
|
Anovulatory DUB
|
menarche and perimenopause; estrogen excess without progesterone
|
|
Ovulatory DUB
|
irregular shedding, inadequate luteal phase
|
|
Primary amenorrhea
|
no menses by 16 years old
|
|
Secondary amenorrhea
|
no menses for 3 months
|
|
Amenorrhea-hypothalamic/pituitary dysfunction
|
dec FSH/LH; e.g., hypopituitarism
|
|
Amenorrhea-ovarian dysfunction
|
inc FSH/LH; e.g., Turner's syndrome
|
|
Amenorrhea-end-organ disease
|
normal FSH/LH; e.g., imperforate hymen
|
|
Asherman syndrome
|
surgical removal of stratum basalis
|
|
Primary amenorrhea-normal secondary sex characteristics
|
constitutional delay MCC
|
|
Primary amenorrhea-lack secondary sex characteristics
|
Turner's
|
|
Turner's syndrome
|
XO; no Barr bodies; XO/XY types have gonadoblastomas; streak gonads (no eggs)
|
|
S/S of Turner's syndrome
|
newborn with lymphedema hands/feet; cystic hygroma in neck (web); short stature; primary amenorrhea
|
|
Secondary amenorrhea
|
pregnancy MCC; prolactinoma; anorexia nervosa; pituitary adenoma
|
|
Asherman syndrome
|
removal of stratum basalis causing scarring; secondary amenorrhea
|
|
Endometritis
|
group B streptococcus; intrauterine device (Actinomyces); chronic- plasma cells
|
|
Endometrial polyp
|
menorrhagia; not a precursor for endometrial cancer
|
|
Adenomyosis
|
functioning endometrial glands and stroma in myometrium; enlarged uterus
|
|
Endometriosis
|
functioning glands and stroma outside uterus; reverse menses; ovary MC site
|
|
S/S of Endometriosis
|
dysmenorrhea, painful stooling, bowel obstruction; "powder burn" appearance
|
|
Endometrial hyperplasia
|
unopposed estrogen; simple/complex types; precursor endometrial cancer
|
|
Causes of endometrial hyperplasia
|
obesity, estrogen Rx, polycystic ovarian syndrome
|
|
Endometrial cancer
|
obesity, nulliparity, estrogen Rx, early menarche/late menopause; OC protective
|
|
S/S of Endometrial cancer
|
bleeding in postmenopausal woman
|
|
Leiomyoma uterus
|
menorrhagia, obstructive delivery ; not a precursor for leiomyosarcoma
|
|
Leiomyosarcoma
|
MC sarcoma: necrosis + atypical mitotic spindles
|
|
Ectopic pregnancy
|
PID MC risk factor; intraperitoneal hemorrhage; screen with (Beta-hCG)
|
|
Follicular cyst
|
MC ovarian mass in young woman
|
|
Risk factors for ovarian tumors
|
nulliparity and genetic factors; OC protective
|
|
Serous ovarian tumors
|
surface-derived; l' bilaterality; psammoma bodies in malignant type
|
|
Mucinous ovarian tumors
|
surface-derived; pseudomyxoma peritonei in malignant type
|
|
Endometrioid carcinoma
|
resembles endometrial cancer; association with endometriosis
|
|
Cystic teratoma
|
MC benign germ cell tumor (<1% malignant); hair/teeth; calcifications
|
|
Dysgerminoma
|
MC malignant germ cell tumor; associated with streak gonads of Turners
|
|
Yolk sac tumor
|
MC germ cell tumor young girl; TAFP; Schiller-Duval bodies
|
|
Meigs syndrome
|
ovarian fibroma, ascites, right-sided pleural effusion
|
|
Granulosa tumor
|
low grade malignant; hyperestrinism, Call Exner bodies
|
|
Thecoma
|
benign; yellow color; hyperestrinism
|
|
Leydig cell and Sertoli cell tumors
|
hyperandrogenism
|
|
Gonadoblastoma
|
XY phenotype of Turner's
|
|
Krukenberg tumors
|
metastatic stomach cancer; signet ring cells
|
|
Single umbilical artery
|
inc incidence of congenital defects
|
|
Syncytiotrophoblast
|
lining of villi; produces hCG and human placental lactogen
|
|
Human placental lactogen
|
responsible for mild glucose intolerance in pregnancy
|
|
Abruptio placenta
|
retroplacental clot; painful bleeding; hypertension, cocaine, smoking
|
|
Placenta previa
|
placenta implanted over cervical os; painless bleeding
|
|
Placenta accreta
|
direct implantation into myometrium without intervening decidua; hysterectomy
|
|
Twin placenta
|
monochorionic always identical twins; dichorionic may be identical or fraternal
|
|
Siamese twins
|
monoamniotic monochorionic twin placenta
|
|
Enlarged placenta found in
|
DM, Rh HDN, syphilis
|
|
Complete hydatiform mole
|
benign neoplasm of chorionic villi; dilated villi; no embryo; 46 XX (both male)
|
|
S/S of a complete hydatiform mole
|
preeclampsia in first trimester; inc incidence choriocarcinoma
|
|
Partial mole
|
embryo present; 68 XXY; no transformation into choriocarcinoma
|
|
Choriocarcinoma
|
malignancy of trophoblastic tissue (syncytiotrophoblast, cytotrophoblast)
|
|
risk factors for Choriocarcinoma
|
complete mole (MC), spontaneous abortion, normal pregnancy
|
|
S/S of choriocarcinoma
|
inc hCG; lung metastasis; good prognosis
|
|
Chorioamnionitis
|
group B streptococcus (S. agalactiae) infection
|
|
Preeclampsia
|
abnormal placentation causing placental ischemia; inc in vasoconstrictors (ATII)
|
|
S/S of Preeclampsia
|
hypertension, proteinuria, pitting edema; begins in third trimester
|
|
Spontaneous abortion
|
50% have karyotype deformity (trisomy 16)
|
|
Amniotic fluid
|
fetal urine
|
|
Polyhydramnios
|
TE fistula, duodenal atresia, open neural tube defects
|
|
Oligohydramnios
|
infantile polycystic disease
|
|
inc Serum AFP in pregnancy
|
open neural tube defect
|
|
dec Serum AFP in pregnancy
|
Down's Syndrome
|
|
Urine estriol
|
fetal adrenal, placental, maternal liver involved in its production
|
|
Down syndrome triad
|
inc beta-hCG, dec serum AFP, dec urine estriol
|
|
FCC
|
MC breast mass < 50-yrs-old; atypical hyperplasia cancer risk; lumpy, painful breasts
|
|
Sclerosing adenosis
|
component of FCC; involves terminal lobules often has microcalcifications
|
|
Fibroadenoma
|
benign stromal tumor; MC movable mass in women < 35-yrs-old
|
|
Intraductal papilloma
|
benign tumor lactiferous duct/sinus; MCC bloody nipple discharge < 50-yr-old
|
|
Invasive ductal cancer
|
MCC breast mass in woman > 50-yrs-old
|
|
Breast cancer risks
|
unopposed estrogen; family history first-degree relatives
|
|
Breast cancer
|
painless mass upper outer quadrant in woman > 50-yrs-old
|
|
Mammography
|
screening test to detect non-palpable masses
|
|
Palpable breast mass
|
order fine needle aspiration (not a mammogram)
|
|
Ductal carcinoma in situ
|
necrotic centers (comedo); microcalcifications common
|
|
Paget's disease of breast
|
invasive ductal cancer into nipple; Paget's cells similar to vulvar Paget's
|
|
Medullary carcinoma
|
bulky tumor with large cells and lymphoid infiltrate
|
|
Inflammatory carcinoma
|
orange peel appearance; lymphatics blocked by tumor (lymphedema)
|
|
Lobular cancer
|
MC cancer of terminal lobule; inc bilaterality
|
|
Phyllodes tumor
|
low grade malignant tumor of stroma
|
|
ERA-PRA positive tumors
|
tumors responding to hormones; candidate for tamoxifen (anti-estrogen)
|
|
ERB-B2 oncogene positive breast cancer
|
aggressive breast cancer
|
|
Gynecomastia
|
estrogen stimulation of male breast
|
|
Gynecomastia
|
normal in newborn, puberty (no surgery), old age; cirrhosis MC pathologic cause
|